Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.

Fazle Rabbi ChowdhuryAshraful HoqueForhad Uddin Hasan ChowdhuryMd Ruhul AminAbdur RahimM Mujibur RahmanRubina YasminMd Robed AminMd Titu MiahMd Abul KalamMd Sayedur Rahman

Published in: Trials (2020)

Clinicaltrials.gov ID: NCT04403477 . Registered 26 May, 2020 FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trial's website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this letter serves as a summary of the key elements of the full protocol.

Keyphrases

randomized controlled trial
study protocol
phase ii
open label
clinical trial
phase iii
placebo controlled
sars cov
double blind
systematic review